EP4156947A4 - Extrakt mit oleandrin und verfahren zur herstellung davon - Google Patents

Extrakt mit oleandrin und verfahren zur herstellung davon Download PDF

Info

Publication number
EP4156947A4
EP4156947A4 EP21812882.5A EP21812882A EP4156947A4 EP 4156947 A4 EP4156947 A4 EP 4156947A4 EP 21812882 A EP21812882 A EP 21812882A EP 4156947 A4 EP4156947 A4 EP 4156947A4
Authority
EP
European Patent Office
Prior art keywords
oleandrine
production
extract containing
extract
containing oleandrine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21812882.5A
Other languages
English (en)
French (fr)
Other versions
EP4156947A1 (de
Inventor
Richard J. OBISO
Robert A. Newman
Otis C. Addington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phoenix Biotechnology Inc
Original Assignee
Phoenix Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/895,920 external-priority patent/US10729735B1/en
Priority claimed from PCT/US2020/042009 external-priority patent/WO2021201903A1/en
Priority claimed from PCT/US2021/022800 external-priority patent/WO2021202103A2/en
Application filed by Phoenix Biotechnology Inc filed Critical Phoenix Biotechnology Inc
Publication of EP4156947A1 publication Critical patent/EP4156947A1/de
Publication of EP4156947A4 publication Critical patent/EP4156947A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/30—Other Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Compounds Of Unknown Constitution (AREA)
EP21812882.5A 2020-05-24 2021-05-19 Extrakt mit oleandrin und verfahren zur herstellung davon Pending EP4156947A4 (de)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202063029530P 2020-05-24 2020-05-24
US202063034800P 2020-06-04 2020-06-04
US16/895,920 US10729735B1 (en) 2016-09-14 2020-06-08 Method and compostitions for treating coronavirus infection
US202063042656P 2020-06-23 2020-06-23
US202063051576P 2020-07-14 2020-07-14
PCT/US2020/042009 WO2021201903A1 (en) 2020-03-31 2020-07-14 Method and compositions for treating coronavirus infection
US202063057727P 2020-07-28 2020-07-28
US202063059776P 2020-07-31 2020-07-31
US202163159242P 2021-03-10 2021-03-10
PCT/US2021/022800 WO2021202103A2 (en) 2020-03-31 2021-03-17 Method and compositions for treating coronavirus infection
PCT/US2021/033176 WO2021242590A1 (en) 2020-05-24 2021-05-19 Extract containing oleandrin and method of production thereof

Publications (2)

Publication Number Publication Date
EP4156947A1 EP4156947A1 (de) 2023-04-05
EP4156947A4 true EP4156947A4 (de) 2024-08-14

Family

ID=78722716

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21812882.5A Pending EP4156947A4 (de) 2020-05-24 2021-05-19 Extrakt mit oleandrin und verfahren zur herstellung davon

Country Status (8)

Country Link
EP (1) EP4156947A4 (de)
JP (1) JP7648195B2 (de)
KR (1) KR20230016196A (de)
CN (1) CN116322339A (de)
AU (1) AU2021282086A1 (de)
CA (1) CA3180022A1 (de)
MX (1) MX2022014731A (de)
WO (1) WO2021242590A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112689510B (zh) * 2020-03-31 2022-02-01 菲尼克斯生物技术公司 用于治疗冠状病毒感染的方法和组合物
CN114668773B (zh) * 2022-04-08 2023-10-03 山东中医药大学 重楼提取物在抗克里米亚刚果出血热病毒中的应用
KR102704483B1 (ko) * 2023-02-28 2024-09-10 대한민국(질병관리청 국립보건연구원장) 스테로이드 유도체 계열 화합물 및 이를 유효성분으로 함유하는 항바이러스제
CN118319830B (zh) * 2024-04-22 2025-01-28 广州博科化妆品有限公司 一种紧致皮肤抗皱精华液及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120219620A1 (en) * 2005-07-28 2012-08-30 Phoenix Biotechnology, Inc. SCF Extract Containing Cardiac Glycoside
WO2021202103A2 (en) * 2020-03-31 2021-10-07 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060205679A1 (en) * 2004-10-22 2006-09-14 Azaya Therapeutics, Inc. Topical and oral formulations of cardiac glycosides for treating skin diseases
BR112012017073A2 (pt) * 2010-01-11 2015-09-01 Phoenix Biotechnology Inc Método de tratamento de condições neurológicas com glicosídeos cardíacos
MX345675B (es) 2010-11-22 2017-02-10 Phoenix Biotechnology Inc Metodo para tratar condiciones neurologicas con extracto de especie nerium o especie thevetia.
WO2012129683A1 (en) 2011-03-25 2012-10-04 Biopharmacopae Design International Inc. Extracts from plants of the tsuga genus and uses thereof in the treatment of skin disorders
EP3475402B1 (de) * 2016-06-24 2023-08-02 Cool Clean Technologies, LLC Verfahren zur extraktion von cannabinoiden mittels flüssigem kohlendioxid
US10702567B2 (en) 2016-09-14 2020-07-07 Phoenix Biotechnology, Inc. Method and compositions for treating viral infection
KR20180060726A (ko) * 2016-11-29 2018-06-07 주식회사 엘지생활건강 올레안드린을 포함하는 화장료 조성물
SG11202105728YA (en) 2020-03-31 2021-11-29 Phoenix Biotechnology Inc Method and compositions for treating coronavirus infection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120219620A1 (en) * 2005-07-28 2012-08-30 Phoenix Biotechnology, Inc. SCF Extract Containing Cardiac Glycoside
WO2021202103A2 (en) * 2020-03-31 2021-10-07 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HERRERO MIGUEL ET AL: "Supercritical fluid extraction: Recent advances and applications", JOURNAL OF CHROMATOGRAPHY A, vol. 1217, no. 16, 1 April 2010 (2010-04-01), AMSTERDAM, NL, pages 2495 - 2511, XP093180639, ISSN: 0021-9673, DOI: 10.1016/j.chroma.2009.12.019 *
See also references of WO2021242590A1 *

Also Published As

Publication number Publication date
AU2021282086A1 (en) 2023-01-05
CN116322339A (zh) 2023-06-23
KR20230016196A (ko) 2023-02-01
WO2021242590A1 (en) 2021-12-02
CA3180022A1 (en) 2021-12-02
JP7648195B2 (ja) 2025-03-18
JP2023527979A (ja) 2023-07-03
MX2022014731A (es) 2023-02-27
EP4156947A1 (de) 2023-04-05

Similar Documents

Publication Publication Date Title
EP4156947A4 (de) Extrakt mit oleandrin und verfahren zur herstellung davon
EP3827073A4 (de) Verfahren zur herstellung eines mykologischen produktes und damit hergestelltes produkt
EP3643185A4 (de) Rauchartikelfilter und herstellungsverfahren dafür
EP4030680A4 (de) Anwendungsverarbeitungsverfahren und zugehöriges produkt
EP3915391A4 (de) Proteinreiches produkt aus biertreber und verfahren zu dessen herstellung
EP4176723A4 (de) Geschwollene zusammensetzung mit stärke und verfahren zur herstellung davon
EP2168440A4 (de) Equolhaltiges extrakt, herstellungsverfahren dafür, verfahren zur equolextraktion und equolhaltiges nahrungsmittel
EP3538089A4 (de) Zusammensetzungen mit oroxylin a und verfahren zur extraktion davon
EP3878966A4 (de) Verfahren zur herstellung einer seltenen zuckerhaltigen zusammensetzung und seltene zuckerhaltige zusammensetzung
EP3967750A4 (de) Dreidimensionales gewebekonstrukt und verfahren zur herstellung davon und verfahren zur herstellung einer zellhaltigen zusammensetzung
EP2623107A4 (de) Arctigeninhaltiger klettenfruchtextrakt und verfahren zu seiner herstellung
EP3424877A4 (de) Silberhaltiger calciumphosphat-sinterkörper und verfahren zur herstellung davon
EP4421100A4 (de) Verfahren zur herstellung eines ethylen-vinylalkohol-copolymers und herstellungsverfahren für ethylen-vinylalkohol-copolymer
EP4296309A4 (de) Celluloseacylatzusammensetzung und herstellungsverfahren dafür
EP3778824A4 (de) Ölabweisende und wasserabweisende zusammensetzung, artikel und verfahren zur herstellung eines artikels
EP3670710A4 (de) Durch verarbeitung eines festen kohlenstoffhaltigen materials erhaltener körper und herstellungsverfahren dafür
EP4249516A4 (de) Verfahren zur herstellung von polytetrafluorethylen und zusammensetzung mit polytetrafluorethylen
EP4226974A4 (de) Verfahren zur herstellung einer extraktzusammensetzung
EP4245745A4 (de) Tabakextrakt mit cembratriendiol und herstellungsverfahren dafür
EP4086621A4 (de) Reinigungsverfahren und gereinigtes produkt
EP3932485A4 (de) Zusammensetzung mit aus pflanzen gewonnenem extrakt und/oder aus pflanzen gewonnenem, verarbeitetem produkt
EP4195972A4 (de) Schuhwerk und schuhwerkherstellungsverfahren
EP4166130A4 (de) Scheuermittel, reinigungsmittelhaltige zusammensetzung und verfahren zur herstellung von reinigungsmittel
EP3932536C0 (de) Verbesserte mikrokapseln und verfahren zur herstellung davon
EP4289808A4 (de) 1,4-cyclohexandimethanol-zusammensetzung und reinigungsverfahren dafür

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20221205

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240711

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 17/00 20060101ALI20240705BHEP

Ipc: A61Q 19/00 20060101ALI20240705BHEP

Ipc: A61K 31/7048 20060101ALI20240705BHEP

Ipc: A61K 36/24 20060101ALI20240705BHEP

Ipc: A23L 3/3517 20060101ALI20240705BHEP

Ipc: A23B 7/16 20060101ALI20240705BHEP

Ipc: A23B 7/154 20060101AFI20240705BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250527